Skip to main content
. 2024 Mar 10;14(1):e12351. doi: 10.1002/pul2.12351

Table 2.

Changes in clinical parameters.

Variable Baseline Follow‐up Change (%) p‐value
PASP, mmHg 92.6 ± 30.8 88.3 ± 30.0 −4.3 (−5) 0.050
TR 4.8 ± 0.8 4.6 ± 0.7 −0.2 (−4) 0.450
RA area, cm2 28.4 ± 14.8 27.1 ± 16.1 −1.3 (−5) 0.076
RAP, mmHg 12.1 ± 10.3 9.3 ± 5.0 −2.8 (−23) 0.013
RV diameter, cm 5.1 ± 1.4 5.0 ± 1.4 −0.1 (−2) 0.084
Sm, cm/s 10.5 ± 2.8 10.7 ± 2.3 0.2 (2) 0.236
LVEDD, mm 35.3 ± 7.2 36.9 ± 6.6 1.6 (5) 0.007
LVEF (%) 79.8 ± 6.1 79.8 ± 8.6 0 (0) 1.000
EI 1.9 ± 0.7 1.8 ± 0.6 −0.1 (−5) 0.001
TAPSE, cm 1.6 ± 0.4 1.7 ± 0.4 0.1 (−6) 0.006
PE, n (%) 65 (39.2) 22 (23.4) 0.013

Note: data are presented as n (%), mean ± SD, and interquartile range.

Abbreviations: EI, eccentricity index; LVEDD, left ventricular end‐diastolic dimension; LVEF, left ventricular ejection fraction; PASP, pulmonary arterial systolic pressure; PE, pericardial effusion; RA area, right atrium area; RAP, right atrial pressure; RV, right ventricle; Sm, peak systolic velocity of tricuspid annulus; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.